AAME Atlantic American (AAME) Insider Trading, Ownership & Congress Trades
Insurance · Life insurance · CIK 0000008177
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter
Atlantic American insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
No insider purchases or sales are on record for ATLANTIC AMERICAN CORP in the period covered. Source: SEC Form 4 filings, as of 2026-10-27.
Insider
Filed
Shares
Value
Since filing
Context
- 2 earlier Form 4 trades (code P or S) here by this insider (1 buy, 1 sale), the last on Mar 31, 2022.
- The trade is 26.5% of the 1,130,259 shares held after it.
- No other insider bought within 30 days.
Insider activity: Insider ROBINSON HARRIETT J bought about $900.0K of AAME on Dec 30, 2022.Context
- 2 earlier Form 4 trades (code P or S) here by this insider (1 buy, 1 sale), the last on Mar 31, 2022.
- No other insider sold within 30 days.
Insider activity: Insider ROBINSON HARRIETT J sold about $900.0K of AAME on Dec 30, 2022.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- No other insider sold within 30 days.
Insider activity: Insider ROBINSON HARRIETT J sold about $5.5M of AAME on Mar 31, 2022, the largest insider sale at the company on our record.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 26.6% of the 5,120,555 shares held after it.
- No other insider bought within 30 days.
Insider activity: Insider ROBINSON HARRIETT J bought about $5.5M of AAME on Mar 31, 2022, the largest insider purchase at the company on our record.4 transactions on record · a thin record, read with care
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
no insider buys or sells on file
Congress
no House purchase disclosed in the last 12 months
Funds
under five funds report holding it
Revenue
+11.9% year over year
more than 59% of Insurance
Margin
2.9% net margin
below 74% of Insurance
Buybacks
no share repurchases reported
Short interest
0.7% of the float short (float per yahoo 2026-10-26) · 1.6 days to cover · settled 2026-09-30
below 91% of Insurance
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch AAME
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-59.1%12M
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns AAME: institutional holders (13F)
13F holdings, latest reported quarter
SEC 13F
No reported 13F holders
No fund above the reporting threshold listed this stock last quarter. That is a fact, not missing data.
Congress trades in AAME
No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
AAME planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
Each figure here is a federal filing, dated the day it went public, so you can test what was knowable then.
AAME financials
Revenue growth
+11.9%
XBRL, annual
Net margin
2.9%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$210.4M
four quarters, 2025-01-01 to 2025-12-31
Revenue, TTM AAME
| FY Dec 2025 | $210.4M |
| FY Dec 2024 | $188.2M |
| FY Dec 2023 | $186.8M |
| FY Dec 2022 | $187.9M |
| FY Dec 2021 | $199.6M |
| Dec 2025 | $51.3M |
| Sep 2025 | $53.8M |
| Jun 2025 | $55.3M |
| Mar 2025 | $50.1M |
| Dec 2024 | $49.0M |
| Sep 2024 | $44.5M |
| Jun 2024 | $47.7M |
| Mar 2024 | $47.0M |
At each fiscal year end
Single quarter
Net margin, TTM
+2.9%
net income over revenue, 2025-01-01 to 2025-12-31
Net margin, TTM AAME
| FY Dec 2025 | +2.9% |
| FY Dec 2024 | -0.7% |
| FY Dec 2023 | -0.1% |
| FY Dec 2022 | +0.8% |
| FY Dec 2021 | +2.1% |
| Dec 2025 | +2.6% |
| Sep 2025 | +1.1% |
| Jun 2025 | +6.0% |
| Mar 2025 | +1.6% |
| Dec 2024 | +6.7% |
| Sep 2024 | -4.5% |
| Jun 2024 | -1.4% |
| Mar 2024 | -4.3% |
At each fiscal year end
Single quarter
Free cash flow, TTM
$32.4M
operating cash flow minus capex, 2025-01-01 to 2025-12-31
Free cash flow, TTM AAME
| FY Dec 2025 | $32.4M |
| FY Dec 2024 | $4.6M |
| FY Dec 2023 | $2.5M |
| FY Dec 2022 | $6.3M |
| FY Dec 2021 | $981.0K |
| Dec 2025 | $17.7M |
| Sep 2025 | $6.6M |
| Jun 2025 | $9.1M |
| Mar 2025 | -$986.0K |
| Dec 2024 | $9.5M |
| Sep 2024 | $58.0K |
| Jun 2024 | $361.0K |
| Mar 2024 | -$5.4M |
At each fiscal year end
Single quarter
Debt to equity
n/a
no debt line filed
Debt to equity AAME
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
| Jun 2024 | n/a |
| Mar 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt line filed
Cash flow to debt AAME
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
| Jun 2024 | n/a |
| Mar 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+5.2%
TTM net income over average of 2024-12-31 and 2025-12-31
Return on equity AAME
| FY Dec 2025 | +5.2% |
| FY Dec 2024 | -1.3% |
| FY Dec 2023 | -0.2% |
| FY Dec 2022 | +1.3% |
| FY Dec 2021 | +3.0% |
| Dec 2025 | +5.2% |
| Sep 2025 | +7.4% |
| Jun 2025 | +5.2% |
| Mar 2025 | +1.4% |
| Dec 2024 | -1.3% |
| Sep 2024 | -6.8% |
| Jun 2024 | -3.1% |
| Mar 2024 | -0.7% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+1.5%
TTM net income over average of 2024-12-31 and 2025-12-31
Return on assets AAME
| FY Dec 2025 | +1.5% |
| FY Dec 2024 | -0.4% |
| FY Dec 2023 | -0.0% |
| FY Dec 2022 | +0.4% |
| FY Dec 2021 | +1.1% |
| Dec 2025 | +1.5% |
| Sep 2025 | +2.0% |
| Jun 2025 | +1.3% |
| Mar 2025 | +0.4% |
| Dec 2024 | -0.4% |
| Sep 2024 | -1.8% |
| Jun 2024 | -0.8% |
| Mar 2024 | -0.2% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital AAME
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
| Jun 2024 | n/a |
| Mar 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed AAME
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
| Jun 2024 | n/a |
| Mar 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
4.77x
close 2026-10-26 over four quarters of diluted EPS, 2025-01-01 to 2025-12-31
P/E, trailing AAME
| FY Dec 2025 | 10.88x |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | 46.80x |
| FY Dec 2021 | 12.89x |
| Dec 2025 | 10.88x |
| Sep 2025 | 8.20x |
| Jun 2025 | 9.26x |
| Mar 2025 | 42.50x |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
| Jun 2024 | n/a |
| Mar 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no debt line filed
Enterprise value AAME
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
| Jun 2024 | n/a |
| Mar 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+128.1%
TTM free cash flow over market value at close 2026-10-26
FCF yield AAME
| FY Dec 2025 | +56.1% |
| FY Dec 2024 | +14.6% |
| FY Dec 2023 | +5.1% |
| FY Dec 2022 | +13.3% |
| FY Dec 2021 | +2.0% |
| Dec 2025 | +56.1% |
| Sep 2025 | +41.4% |
| Jun 2025 | +40.7% |
| Mar 2025 | +25.8% |
| Dec 2024 | +14.6% |
| Sep 2024 | +3.5% |
| Jun 2024 | +7.3% |
| Mar 2024 | +15.5% |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
prior-year trailing EPS was a loss, growth undefined
PEG, trailing AAME
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
| Jun 2024 | n/a |
| Mar 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Revenue | $210.4M | $188.2M | $186.8M | $187.9M |
| Operating income | $3.7M | -$1.3M | $1.5M | $9.6M |
| Net income | $6.0M | -$1.4M | -$171.0K | $1.5M |
| EPS (diluted) | 0.28 | -0.09 | -0.03 | 0.06 |
| Operating cash flow | $32.9M | $4.8M | $2.6M | $6.5M |
| Cash | $43.6M | $35.6M | $28.3M | $28.9M |
| Dividends paid | $408.0K | $408.0K | $408.0K | $408.0K |
SEC XBRL, fiscal years, as known on 2026-10-27
AAME Stock Sonar score 3/7 axes
Find similar shapesCompareAAME ranks highest on risk and compliance (90th percentile) and growth (59th), and lowest on profitability (28th), among Insurance peers.
3 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
